Bio-Techne (TECH) Cost of Revenue (2009 - 2026)

Bio-Techne's Cost of Revenue history runs 18 years deep, the most recent figure standing at $103.1 million for Q1 2026.

• On a quarterly basis, Cost of Revenue rose 1.48% year-over-year to $103.1 million in Q1 2026; TTM through Mar 2026 was $424.3 million, a 2.5% increase from a year earlier, with the FY2025 full-year figure at $429.4 million, up 10.28% from the prior year.
• Cost of Revenue retreated to $103.1 million in Q1 2026 per TECH's latest filing, from $104.6 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $118.2 million in Q2 2025 and bottomed at $87.9 million in Q2 2022.
• The 5-year median for Cost of Revenue is $98.4 million (2025), against an average of $98.2 million.
• Across the five-year window, Cost of Revenue advanced 18.12% in 2022 and retreated 7.51% in 2025, its largest moves.
• Year by year, Cost of Revenue stood at $88.2 million in 2022, then rose by 8.83% to $96.0 million in 2023, then grew by 7.43% to $103.1 million in 2024, then rose by 1.41% to $104.6 million in 2025, then slipped by 1.41% to $103.1 million in 2026.
• Per Business Quant, the three latest TECH Cost of Revenue figures stand at $103.1 million (Q1 2026), $104.6 million (Q4 2025), and $98.4 million (Q3 2025).